BM
IRWD icon

Bridger Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bridger Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-916,314
Closed -$9.49M – 31
2022
Q3 		$9.49M Sell
916,314
-39,700
-4% -$450K 2.87% 14
2022
Q2 		$11M Buy
956,014
+26,300
+3% +$310K 2.48% 18
2022
Q1 		$11.7M Hold
929,714
– – 1.92% 19
2021
Q4 		$10.8M Sell
929,714
-40,800
-4% -$501K 1.4% 26
2021
Q3 		$12.7M Sell
970,514
-1,064,600
-52% -$13.8M 1.48% 24
2021
Q2 		$26.2M Sell
2,035,114
-817,300
-29% -$9.36M 2.44% 18
2021
Q1 		$31.9M Buy
2,852,414
+385,442
+16% +$4.07M 2.98% 17
2020
Q4 		$28.1M Sell
2,466,972
-308,495
-11% -$3.38M 2.14% 21
2020
Q3 		$25M Buy
2,775,467
+852,434
+44% +$8.47M 2% 21
2020
Q2 		$19.8M Buy
1,923,033
+378,443
+25% +$3.87M 1.84% 22
2020
Q1 		$15.6M Buy
+1,544,590
New +$18.2M 1.8% 24
2019
Q2 		– Sell
-4,993,179
Closed -$56.6M – 33
2019
Q1 		$56.6M Hold
4,993,179
– – 4.48% 8
2018
Q4 		$43.3M Buy
4,993,179
+4,250,641
+572% +$48.8M 3.61% 12
2018
Q3 		$11.5M Buy
+742,538
New +$11.7M 0.66% 34
2017
Q4 		– Sell
-3,040,037
Closed -$40.2M – 34
2017
Q3 		$40.2M Buy
3,040,037
+1,684,513
+124% +$23.2M 2.4% 22
2017
Q2 		$21.4M Sell
1,355,524
-517,411
-28% -$7.52M 1.22% 33
2017
Q1 		$26.8M Sell
1,872,935
-370,965
-17% -$5.07M 1.53% 32
2016
Q4 		$28.7M Sell
2,243,900
-2,441,754
-52% -$30.8M 2% 23
2016
Q3 		$62.3M Sell
4,685,654
-2,380,036
-34% -$27.8M 4.2% 8
2016
Q2 		$77.4M Buy
7,065,690
+882,408
+14% +$8.62M 5% 5
2016
Q1 		$56.7M Buy
6,183,282
+279,437
+5% +$2.3M 3.92% 8
2015
Q4 		$57.3M Buy
5,903,845
+233,806
+4% +$2.26M 1.89% 12
2015
Q3 		$49.5M Buy
5,670,039
+2,673,036
+89% +$24.9M 3.37% 13
2015
Q2 		$30.3M Buy
2,997,003
+1,993,471
+199% +$23.2M 0.96% 29
2015
Q1 		$13.4M Buy
+1,003,532
New +$13.2M 0.9% 34

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bridger Management's IRWD Position: Q4 2022 in Review

Bridger Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 916,314 shares — an estimated $9.49M sold.

Bridger Management first reported a position in IRWD in Q1 2015 and held it in 25 quarters. The position peaked at $77.4M in Q2 2016. 250 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

  • Bridger Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Bridger Management sold 916,314 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $9.49M.
  • Bridger Management first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 25 quarters.
  • Bridger Management's Ironwood Pharmaceuticals position peaked at $77.4M in Q2 2016.
  • 250 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on Bridger Management's 13F filing for Q4 2022, filed 15 Feb 2023.